|
|
| Line 1: |
Line 1: |
| {{ICD10 transition status | | {{ICD10 transition status |
| | OldDxArticle =Lymphoma| CurrentStatus = reconciled | | | OldDxArticle =Lymphoma |
| | | CurrentStatus = reconciled |
| | InitialEditorAssigned = Debbie Page-Newton | | | InitialEditorAssigned = Debbie Page-Newton |
| }} | | }} |
| Line 11: |
Line 12: |
|
| |
|
| == Additional Info == | | == Additional Info == |
| *Non-Hodgkin (Most people with lymphoma have this type): is a group of blood cancers that includes all types of lymphoma except Hodgkin's lymphomas. T-cell lymphomas account for approximately 15 percent of all NHLs in the United States.
| | Non-Hodgkin lymphoma is the most common |
| **Symptoms include enlarged lymph nodes, fever, night sweats, weight loss, and tiredness. Other symptoms may include bone pain, chest pain, or itchiness. Some forms are slow growing while others are fast growing.
| |
| **Risk factors include poor immune function, autoimmune diseases, Helicobacter pylori infection, hepatitis C, obesity, and Epstein-Barr virus infection.
| |
| **Treatment depends on whether the lymphoma is slow or fast growing and if it is in one area or many areas. Treatments may include chemotherapy, radiation, immunotherapy, targeted therapy, stem cell transplantation, surgery, or watchful waiting. If the blood becomes overly thick due to antibodies, plasmapheresis may be used. Radiation and some chemotherapy, however, increase the risk of other cancers, heart disease or nerve problems over the subsequent decades
| |
| *Mantel cell lymphoma is one of several types of B cell Non-Hodgkin's lymphoma. 6% of non-Hodgkin lymphoma cases are mantle cell lymphoma
| |
|
| |
|
| == Alternate ICD10s to consider coding instead or in addition == | | == Alternate ICD10s to consider coding instead or in addition == |